Blogs about: Drug Approval
Featured Blog
NICE says no to three drugs for advanced kidney cancer
NICE are set to reject three kidney cancer drugs The National Institute of Health and Clinical Excellence (NICE) has announced its final decision on whether people with advanced kidney cancer can have… more →
Cancer Research UK - Science Update
Idea #98 for May 27th, 2009: Nowhere To Go But Up or Change at the FDA
health365 wrote 1 month ago: The new leadership at the FDA is promising to change the way the organization operates, along with c … more →
NICE says no to three drugs for advanced kidney cancer
Henry Scowcroft wrote 2 months ago: NICE are set to reject three kidney cancer drugs The National Institute of Health and Clinical Excel … more →
Spilt the FDA? Not so quick.
— 3 comments
Audrey Spolarich wrote 3 months ago: While it is not getting a great deal of attention in the traditional or new media, the issue of whet … more →
Legislation Would Give 12 Years Of Market Exclusivity To Brand-Name Biologic Drug Manufacturers
finestitcher wrote 4 months ago: Medical News Today, Article Date: 19 Mar 2009 – 5:00 PDT Rep. Anna Eshoo (D-Calif.), House Ene … more →
Orion Corporation Withdraws Its Application For An Extension Of Indication for Stalevo (levodopa/carbidopa/entacapone)
— 1 comment
finestitcher wrote 4 months ago: PharmaLive, March 10, 2009 LONDON, March 10, 2009–The European Medicines Agency (EMEA) has bee … more →
Commentary: PITTS/GOLDBERG: Getting it right with modern drugs
finestitcher wrote 4 months ago: The Washington Times, by Peter Pitts and Robert Goldberg,Monday, March 2, 2009 Congress and Presiden … more →
NICE recommends Sutent (sunitinib) for advanced kidney cancer
— 7 comments
Henry Scowcroft wrote 5 months ago: NICE has been deliberating over whether to recommend drugs to treat kidney cancer Six months after t … more →
NICE meets to decide about kidney cancer drugs - we were there
— 2 comments
Emma Gilgunn-Jones wrote 5 months ago: NICE are deciding whether to fund four new drugs for advanced kidney cancer 35 experts, 7 administra … more →
The Pharmaceutical Price Regulation Scheme - cutting the cost of cancer drugs
Hilary Jackson wrote 6 months ago: A new pricing scheme should lead to cheaper cancer drugs With the New Year upon us and the sound of … more →
Towards responsible use of cognitive-enhancing drugs by the healthy
clevercourtier wrote 7 months ago: Greely, Henry, et al. “Towards responsible use of cognitive-enhancing drugs by the healthy. … more →
Whining About the Government
— 5 comments
fakename2 wrote 7 months ago: This is a somewhat misleading title, since I really plan to whine about people who whine about the g … more →
NCRI session - The cost of cancer care
— 6 comments
Helen George wrote 9 months ago: One of the sessions at this year’s NCRI conference was on the theme of ‘The cost of canc … more →
Drug authority may require patent for approval of biosimilar drugs
— 1 comment
Prashant wrote 1 year ago: The Hind Business Line reports that the Drug Regulatory Authority in India is “considering a p … more →
Approval of safe drugs without effectiveness data: is it a real option?
Sitemaster wrote 1 year ago: The biotech investor community and many others have demonstrated profound difficulty in recent years … more →
Congress Must Act Quickly to Address Growing Crisis At the Food and Drug Administration
— 1 comment
ppjg wrote 1 year ago: Public Citizen’s Sidney M. Wolfe, M.D., Testifies Before House Subcommittee WASHINGTON, D.C. – The F … more →
Have your say. Start a blog.
See our free features →
An 
Ruckus
